Finance

Beta
Lists
BXP:LON
Beximco Pharmaceuticals GDR
GBX 42.00
0.00%
(0.00) 1D
Dec 31, 1:44:00 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for BXP...
Avg. vol.
0.00
Volume
0.00
52-wk high
GBX 52.33
52-wk low
GBX 33.33
Shares outstanding
405.56M
No. of employees
1K
Avg. vol.
0.00
Volume
0.00
52-wk high
GBX 52.33
52-wk low
GBX 33.33
Shares outstanding
405.56M
No. of employees
1K
News stories
From sources across the web
About Beximco Pharmaceuticals GDR
CEO-
Employees1.12K
Founded1976
HeadquartersDhaka, Dhaka District, Bangladesh
SectorPharmaceutical industry
Previous reportsAll values in BDT
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BDT
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Revenue
10.99B
11.34B
11.71B
12.30B
Cost of goods sold
6.18B
6.45B
6.33B
6.73B
Cost of revenue
6.18B
6.45B
6.33B
6.73B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.91B
2.83B
2.93B
3.17B
Operating expense
2.91B
2.83B
2.93B
3.17B
Total operating expenses
9.10B
9.28B
9.26B
9.90B
Operating income
1.89B
2.06B
2.45B
2.40B
Other non operating income
114.88M
43.61M
33.50M
206.49M
EBT including unusual items
1.72B
1.91B
2.19B
2.40B
EBT excluding unusual items
1.72B
1.91B
2.20B
2.40B
Income tax expense
349.25M
415.57M
502.00M
553.95M
Effective tax rate
20.35%
21.78%
22.88%
23.11%
Other operating expenses
-
-
-
-
Net income
1.36B
1.48B
1.68B
1.83B
Net profit margin
12.42%
13.04%
14.35%
14.88%
Earnings per share
-
-
-
-
Interest and investment income
-
4.19M
6.28M
-
Interest expense
-289.03M
-260.31M
-278.44M
-209.53M
Net interest expenses
-289.03M
-256.12M
-272.17M
-209.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.39B
2.26B
2.95B
2.91B
Gain or loss from assets sale
-15.61M
847.48K
9.52M
-2.06M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more